Explore our sister journals here.

Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Journal of Medical Internet Research

Date Submitted: Mar 27, 2021
Date Accepted: May 13, 2021
Date Submitted to PubMed: May 14, 2021

The final, peer-reviewed published version of this preprint can be found here:

Authors’ Reply to: Methodological Clarifications and Generalizing From Weibo Data. Comment on “Nature and Diffusion of COVID-19–related Oral Health Information on Chinese Social Media: Analysis of Tweets on Weibo”

TAO ZY, Su YX

Authors’ Reply to: Methodological Clarifications and Generalizing From Weibo Data. Comment on “Nature and Diffusion of COVID-19–related Oral Health Information on Chinese Social Media: Analysis of Tweets on Weibo”

J Med Internet Res 2021;23(5):e29145

DOI: 10.2196/29145

PMID: 33989166

PMCID: 8189717

Authors' Reply to: Methodological Clarifications and Generalizing from Weibo Data. Comment on "Nature and Diffusion of COVID-19–related Oral Health Information on Chinese Social Media: Analysis of Tweets on Weibo"

  • Zhuo-Ying TAO; 
  • Yu-Xiong Su

ABSTRACT

N.A


 Citation

Please cite as:

TAO ZY, Su YX

Authors’ Reply to: Methodological Clarifications and Generalizing From Weibo Data. Comment on “Nature and Diffusion of COVID-19–related Oral Health Information on Chinese Social Media: Analysis of Tweets on Weibo”

J Med Internet Res 2021;23(5):e29145

DOI: 10.2196/29145

PMID: 33989166

PMCID: 8189717

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.